TerminatedNo phase
Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)
Key facts
- Who runs it
- Johns Hopkins University
- Where
- Baltimore, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 15 people enrolled
- Started
- 7 May 2024
- Ended
- 8 Apr 2025
- Type of study
- Observational, 3 groups
- Record updated
- 7 May 2025
- Why it stopped
- Occurrence of unforeseen study issues and a presence of unanticipated risks that cannot be adequately quantified.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Male and female adults over the age of 18 who have been diagnosed with SLE and are able to undergo a kidney MRI
Who cannot take part
- Any patient that has undergone a renal transplant
- Any patient that is receiving renal dialysis
Where in United States
- Johns Hopkins University School Of MedicineBaltimore, United StatesNo longer taking part
About the trial
What the trial wants to find out
This study is being done to find out if a non-invasive Magnetic Resonance Imaging (MRI) examination of the kidneys may be helpful in patients with systemic lupus erythematosus (SLE).
The 3 groups in the trial
- Known Lupus Nephritis, with elevated UPCR result
Patients will have one scan at baseline, and one every 4 weeks thereafter for 3 visits. The final imaging session is after 6 months of routine therapy.
- No known lupus nephritis
Patients will have one MRI
- Known Lupus Nephritis, with normal Urine Protein Creatinine Ratio (UPCR) result
Patients will have one scan at baseline, and one every 4 weeks thereafter for 3 visits.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 7 May 2025